U.S. Intrauterine Devices Market Size By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), By Zone, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

U.S. Intrauterine Devices Market Size By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), By Zone, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

The U.S. intrauterine devices market is projected to foresee commendable growth in coming years owing rising awareness regarding the benefits of intrauterine devices, inclination towards delaying pregnancy, and growing use of hormonal IUD due to reduced risk of certain health issues. Intrauterine devices are referred as small devices placed inside uterus to prevent the process of insemination.

These devices are known to be popular across the world and are one of the most effectual forms of birth control as well as an excellent birth control choice for most women. Some intrauterine devices approved for use in the U.S also contain medications that are released over time for facilitating the contraceptive effect.

At present, there are four brands of IUDs available in the U.S., namely Skyla, Liletta, Mirena, and Kyleena, which are hormonal IUDs that use progestin. The country also has ParaGard, a non-hormonal copper intrauterine device. Both kinds of intrauterine devices are 99% effective when it comes to preventing pregnancy. These are in fact one of the most effective birth control types available in the market.

Intrauterine devices are considered safe to use even while breastfeeding, are known to be long lasting, cost-effective and are also hassle free. It is also easy to use and maintain. These advantages will thus drive the product demand over the coming time period.

The U.S. intrauterine devices market is bifurcated into product, age group, and regional zone.

With respect to product, the U.S. intrauterine devices market is classified into Hormonal intrauterine device and Copper intrauterine device. Hormonal intrauterine device segment was valued at around $740 million in 2020 and is expected to grow at a CAGR of 10.3% over the forthcoming time period. This anticipated growth is ascribed to the reduced risk of certain health issues. The four types of hormonal IUDs, namely liletta, Skyla, Kyleena, and Mirena typically release small amounts of the hormone progestin in women. It is the same hormone present in most of the birth control pills.

Progestin acts to thicken cervical mucus, forming a barrier to sperm, reducing the lining of the uterus unwelcoming to implantation of an egg. Thus, these kinds of intrauterine device tend to make period lighter and are also considered a good option for women having heavy periods.

In terms of age group, the overall market is segmented into 45+, 40-44, 35-39, 30-34, 25-29, 20-24, and 15-19. Among these, 20-24 years of age group segment was valued at more than $153 million in 2020 and is anticipated to grow at 9.5% over the forecast time period owing to the inclination towards delaying pregnancy.

From a regional frame of reference, in 2020, Pacific Central zone market was valued at more than $145 million and is projected to grow at more than 9.9% over the forthcoming time period owing to rising awareness regarding the usage of intrauterine devices.